L-DOPA IN POSTENCEPHALITIC PARKINSONISM
- 12 April 1969
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 293 (7598), 744-747
- https://doi.org/10.1016/s0140-6736(69)91751-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- TREATMENT OF PARKINSON'S SYNDROME WITH L-DOPA A DOUBLE BLIND STUDYActa Neurologica Scandinavica, 2009
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Cholinergic-Anticholinergic Antagonism in ParkinsonismArchives of Neurology, 1967
- Was leistet L-Dopa bei der Behandlung der Parkinson-Akinese?*Deutsche Medizinische Wochenschrift (1946), 1967
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967
- Reciprocal Effects on α‐ and γ‐Motoneurones of Drugs Influencing Monoaminergic and Gholinergic TransmissionActa Physiologica Scandinavica, 1966
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963
- Dihydroxyphenylalanine in Extrapyramidal DiseaseJAMA, 1963
- Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-AkineseArchiv Fur Psychiatrie Und Nervenkrankheiten, 1962
- A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONʼS DISEASEJournal of Nervous & Mental Disease, 1961